https://www.selleckchem.com/pr....oducts/rituximab.htm
tients, with estimates varying across geographic locations. Additional studies are needed to better understand the underlying mechanisms and optimal treatment of AKI in these patients. This article presents a summary of the 2017 Annual Report of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry and describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 37 countries. The ERA-EDTA Registry received individual patient data on patients undergoing RR
Like
Comment
Share
